Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Diabetes & Metabolic Disorders
Published in: Journal of Diabetes & Metabolic Disorders 1/2023

08-11-2022 | Diabetic Foot | Research article

Adoption of IWGDF guidance on prevention and management of foot problems in diabetes for local use in Iran by ADAPTE methodology: a step toward best practice

Authors: Mahin Nomali, Mohammad Reza Amini, Maryam Aalaa, Mahnaz Sanjari, Mohammad Reza Mohajeri-Tehrani, Hosein Adibi, Mehrnoosh Yarahmadi, Neda Alijani, Hasan Saeidi, Behnam Molavi, Mahlisha Kazemi, Parvin Mansoori, Ensieh Nasli-Esfahani, Bagher Larijani, Neda Mehrdad

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2023

Login to get access

Abstract

Purpose

Adoption of international working group on the diabetic foot (IWGDF) guidance on prevention and management of foot problems in patients with diabetes was the study aim.

Methods

The ADAPTE process consisted of three main phases of set-up, adoption, and finalization with overall 24 steps was used. In set- up phase, organizing committee by a multidisciplinary approach was established. In adoption phase, comprehensive search in databases and guideline resources was done. According to the inclusion criteria, the 2015IWGDF guidance was selected for adoption process. Quality, currency, content and consistency of the guidance were assessed. Also, consensus on different level of agreement for each recommendation were reported. On finalization phase, the adopted version was reviewed by the guidance developer and the final guidance for local use in Iran was disseminated.

Results

The 2015 IWGDF guidance with 77 recommendations was adopted after screening of 1760 documents retrieved from Jan. 2006 to Nov. 2016. An organizing committee was established according to a multidisciplinary approach including 73 members with endocrinology, orthopedic & vascular surgery, dermatology, infectious diseases, physical medicine and rehabilitation specialties, general practitioners and nurses. This guidance obtained a good quality in all six domains of AGREE II instrument (Score ≥ 80%), good currency, content, and consistency. Also, during the third round of Delphi, the consensus on the agreement level of each recommendation were greater than 80% and 77 recommendations of the original guidance were kept in the adopted version.

Conclusion

The 2015 IWGDF guidance with 77 recommendations adopted for local use in different health care settings of Iran.
Appendix
Available only for authorised users
Literature
1.
Woolf SH. Evidence-based medicine and practice guidelines: an overview. Cancer Control. 2000;7(4):362–7.PubMedCrossRef
2.
Institute of Medicine Committee on Clinical Practice. G. In: Field MJ, Lohr KN, editors. Guidelines for clinical practice: From development to use. Washington (DC): National Academies Press (US) Copyright 1992 by the National Academy of Sciences.; 1992.
3.
Graham ID, Harrison MB. Evaluation and adaptation of clinical practice guidelines. Evid Based Nurs. 2005;8(3):68–72.PubMedCrossRef
4.
Field MJ, Lohr KN. Guidelines for clinical practice: from development to use. Washington, DC: National Academies Press; 1992.
5.
Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol. 2001;19(11):2886–97.PubMedCrossRef
6.
Woolf SH. Practice guidelines: a new reality in medicine: I. Recent developments. Arch Intern Med. 1990;150(9):1811–8.PubMedCrossRef
7.
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii–v.PubMedCrossRef
8.
Attia A. Adaptation of international evidence based clinical practice guidelines: The ADAPTE process. Middle East Fertil Soc J. 2013;18(2):123–6.CrossRef
9.
Shoultz J, Phillion N, Noone J, Tanner B. Listening to women: culturally tailoring the violence prevention guidelines from the put prevention into practice program. J Am Acad Nurse Pract. 2002;14(7):307–15.PubMedCrossRef
10.
Shoultz J, Tanner B, Harrigan R. Culturally appropriate guidelines for alcohol and drug abuse prevention. Nurse Pract. 2000;25(11):50–4.PubMedCrossRef
11.
Burgers J, Fervers B, Haugh M, Brouwers M, Browman G, Philip T, et al. International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol. 2004;22(10):2000–7.PubMedCrossRef
12.
Eisinger F, Geller G, Burke W, Holtzman NA. Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet. 1999;353(9156):919–20.PubMedCrossRef
13.
Hart RG, Bailey RD. An assessment of guidelines for prevention of ischemic stroke. Neurology. 2002;59(7):977–82.PubMedCrossRef
14.
Manna D, Bruijnzeels M, Mokkink H, Berg M. Ethnic specific recommendations in clinical practice guidelines: a first exploratory comparison between guidelines from the USA, Canada, the UK, and the Netherlands. Qual Saf Health Care. 2003;12(5):353–8.PubMedPubMedCentralCrossRef
15.
Wils J, O’Dwyer P, Labianca R. Adjuvant treatment of colorectal cancer at the turn of the century: European and US perspectives. Ann Oncol. 2001;12(1):13–22.PubMedCrossRef
16.
Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care. 2006;18(3):167–76.PubMedCrossRef
17.
Graham ID, Harrison MB, Brouwers M, Davies BL, Dunn S. Facilitating the use of evidence in practice: evaluating and adapting clinical practice guidelines for local use by health care organizations. J Obstet Gynecol Neonatal Nurs. 2002;31(5):599–611.PubMedCrossRef
18.
Boulton AJ, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Kirkman MS, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679–85.PubMedPubMedCentralCrossRef
19.
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med. 2017;49(2):106–16.PubMedCrossRef
20.
Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and ischemia to risk of amputation. Diabetes Care. 1998;21(5):855–9.PubMedCrossRef
21.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.PubMedCrossRef
22.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.PubMedCrossRef
23.
International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013.
24.
Cavanagh P, Attinger C, Abbas Z, Bal A, Rojas N, Xu ZR. Cost of treating diabetic foot ulcers in five different countries. Diab/Metab Res Rev. 2012;28(S1):107–11.CrossRef
25.
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii–iv, 1–72. https://​doi.​org/​10.​3310/​hta8060.
26.
Lugtenberg M, Zegers-van Schaick JM, Westert GP, Burgers JS. Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners. Implement Sci. 2009;4(1):1.CrossRef
27.
Wyatt KD, Stuart LM, Brito JP, Leon BC, Domecq JP, Prutsky GJ, et al. Out of context: clinical practice guidelines and patients with multiple chronic conditions: a systematic review. Med Care. 2014;52:92–100.CrossRef
28.
Holmer HK, Ogden LA, Burda BU, Norris SL. Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus. PLoS ONE. 2013;8(4):e58625.PubMedPubMedCentralCrossRef
29.
Raz I. Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36(Supplement 2):139-S44.
30.
Yawn BP, Akl EA, Qaseem A, Black P, Campos-Outcalt D. Identifying Target Audiences: Who Are the Guidelines For? Article 1 in Integrating and Coordinating Efforts in COPD Guideline Development. An Official ATS/ERS Workshop Report. Proc Am Thorac Soc. 2012;9(5):219–24.
31.
Bennett WL, Odelola OA, Wilson LM, Bolen S, Selvaraj S, Robinson KA, et al. Evaluation of guideline recommendations on oral medications for type 2 diabetes mellitus: a systematic review. Ann Intern Med. 2012;156(1 Pt 1):27–36.PubMedCrossRef
32.
Gagliardi AR, Brouwers MC, Palda VA, Lemieux-Charles L, Grimshaw JM. How can we improve guideline use? A conceptual framework of implementability. Implement Sci. 2011;6(1):1.CrossRef
33.
Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(Suppl 2):1–53.PubMedCrossRef
34.
Amiri-Moghaddam S, Heshmat R, Larijani B. Iranian national diabetes research network project: background, mission, and outcomes. Arch Iran Med. 2007;10(1):83–7.PubMed
35.
36.
37.
Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016;32(Suppl 1):2–6.PubMedCrossRef
38.
Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010;182(18):E839–E842.PubMedPubMedCentralCrossRef
39.
Graham I, Harrison M, Brouwers M. Evaluating and adapting practice guidelines for local use: a conceptual framework. Clinical governance in practice London: Harcourt. 2003:213–29.
40.
41.
42.
Glasier A, Brechin S, Raine R, Penney G. A consensus process to adapt the World Health Organization selected practice recommendations for UK use. Contraception. 2003;68(5):327–33.PubMedCrossRef
43.
Naude L, Smart H, Tudhope L, van JanseRensburg G, Alexander H, Abdool-Carrim T, et al. WHASA consensus document on the management of the diabetic foot. Wound Healing Southern Africa. 2015;8(1):17–30.
44.
45.
Bus SA, van Netten JJ, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diab/Metab Res Rev. 2016;32(S1):16–24.CrossRef
46.
Bus SA, Armstrong DG, van Deursen RW, Lewis JEA, Caravaggi CF, Cavanagh PR, et al. IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diab/Metab Res Rev. 2016;32(S1):25–36.CrossRef
47.
Hinchliffe RJ, Brownrigg JRW, Apelqvist J, Boyko EJ, Fitridge R, Mills JL, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes. Diab/Metab Res Rev. 2016;32(S1):37–44.CrossRef
48.
Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diab/Metab Res Rev. 2016;32(S1):45–74.CrossRef
49.
Tricia P. IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diab/Metab Res Rev. 2016;32:75.CrossRef
50.
Diabets foot research group. The adopted guidance on prevention and managment of diabetic foot. Tehran (Iran): Noavaren sina; 2018. [Persian]
51.
Aalaa M, Amini MR, Mehrdad N, Sanjari M, Nomali M, Mohajeri-Tehrani MR, et al. Footwear and offloading interventions to prevent and heal diabetic foot ulcers: Adapted IWGDF guidance. Koomesh. 2022;24(1):57–68.
52.
Amini MR, Mehrdad N, Sanjari M, Aalaa M, Mohajeri-Tehrani MR, Molavi B. Diagnosis, prognosis and treatment of peripheral vascular disease in patients with diabetic foot ulcer: Adopted IWGDF Guidance. Iran J Endocrinol Metab. 2019;21(4):239–52.
53.
Amini MR, Mohajeri-Tehrani MR, Mehrdad N, Sanjari M, Aalaa M, Alijani N. Diagnosis and treatment of diabetic foot infections: adopted IWGDF guidline. Tehran Univ Med J. 2021;79(2):112–23.
54.
Sanjari M, Aalaa M, Amini M, Mehrdad N, Mohajeri M. Prevention and management of foot problems in diabetes: A summary guidance for daily practice based on the iwgdf guidance documents. Iran J Diabetes Lipid Disord. 2020;19(3):123–33.
Metadata
Title
Adoption of IWGDF guidance on prevention and management of foot problems in diabetes for local use in Iran by ADAPTE methodology: a step toward best practice
Authors
Mahin Nomali
Mohammad Reza Amini
Maryam Aalaa
Mahnaz Sanjari
Mohammad Reza Mohajeri-Tehrani
Hosein Adibi
Mehrnoosh Yarahmadi
Neda Alijani
Hasan Saeidi
Behnam Molavi
Mahlisha Kazemi
Parvin Mansoori
Ensieh Nasli-Esfahani
Bagher Larijani
Neda Mehrdad
Publication date
08-11-2022
Publisher
Springer International Publishing
Keyword
Diabetic Foot
Published in
Journal of Diabetes & Metabolic Disorders / Issue 1/2023
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-022-01121-0

Other articles of this Issue 1/2023

Journal of Diabetes & Metabolic Disorders 1/2023 Go to the issue

Research article

HOMA-IR mean values in healthy individuals: a population-based study in iranian subjects

Review Article

Risks associated with acute pancreatitis (AP) with diabetic ketoacidosis (DKA) in COVID-19 patients: a literature review

Research article

KADAM topical warm oxygen therapy device for diabetic foot ulcer-a novel approach

Research article

Beneficial effects of 1,3–1,6 β-glucans produced by Aureobasidium pullulans on non-esterified fatty acid levels in diabetic KKAy mice and their potential implications in metabolic dysregulation

Research article

Hypertonic saline solution 5% as an effective cost-beneficial alternative to normal saline for wound healing in patients with diabetic lower-extremity ulcers: a randomized controlled trial

Research article

A bibliometric perspective to the most cited diabetes articles
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits